Global X Genomics & Biotechnology ETF
$58.17
-47.1%
Aug 10, 2026
C
MarginalGraded against GNOM's own history at this drawdown — not the market's.
What it means: GNOM's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: GNOM is 47.1% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
Global X Genomics & Biotechnology ETF (GNOM) sits 47.1% off its peak and is currently in a severe drawdown, last printing at $58.17. A 35-60% drawdown is the territory where most retail investors capitulate. It's also where the highest-probability historical entries have clustered for resilient assets.
History at this drawdown level is well-populated for GNOM — 64 confirmed observations in the 50%-to-45% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in etfs return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.
For broad-index ETFs the historical base rate is exceptionally stable; for narrow thematic ETFs (e.g., ARKK, cannabis, leveraged), drawdowns are deeper and the sample size at each band is smaller. Severe drawdowns are where Dipsern's segmentation provides the most edge: ordinary base rates don't apply, but the asset's own history at this exact depth does. The forward-return distribution here is bimodal — either rapid recovery or continued decline.
Five tickers closest to GNOM's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for GNOM. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of GNOM's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for GNOM.
Dipsern is research and a second opinion — not a broker. You'd buy GNOM at your own broker.
Analyze GNOM FreeNo credit card required · 5 free analyses per month
Signal computed Aug 10, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.